NDC 72974-415 – Myfembree
Relugolix 40 mg/1; Estradiol Hemihydrate 1 mg/1; Norethindrone Acetate .5 mg/1 · Tablet, Film Coated · Oral
Product NDC72974-415
Product details
- Brand name
- Myfembree
- Generic name
- Relugolix, estradiol hemihydrate, and norethindrone acetate
- Labeler
- Sumitomo Pharma America, Inc
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA214846
- Marketed since
- May 26, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Estrogen; Gonadotropin Releasing Hormone Receptor Antagonist; Progestin
Active ingredients
- Relugolix 40 mg/1
- Estradiol Hemihydrate 1 mg/1
- Norethindrone Acetate .5 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 72974-415-01 | 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-01) | May 26, 2021 |
| 72974-415-99 | 7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-99) | Jul 7, 2021 |